Table 1 Patient demographics and clinical characteristics
Characteristic | COVID-19 ARDS (N = 82) | Non-COVID-19 ARDS (N = 175) | Total (N = 257) | Missing, n (%) |
|---|---|---|---|---|
Age (years) | 43.6 (34.3, 50.4) | 44.6 (33.0, 53.9) | 44.3 (33.2, 52.7) | 0 (0.0%) |
Sex | 0 (0.0%) | |||
Female | 32 (39.0%) | 80 (45.7%) | 112 (43.6%) | |
Male | 50 (61.0%) | 95 (54.3%) | 145 (56.4%) | |
Race | 0 (0.0%) | |||
Black or African American | 22 (26.8%) | 51 (29.1%) | 73 (28.4%) | |
Multiple/other | 5 (6.1%) | 13 (7.4%) | 18 (7.0%) | |
White | 38 (46.3%) | 106 (60.6%) | 144 (56.0%) | |
Unknown/not reported | 17 (20.7%) | 5 (2.9%) | 22 (8.6%) | |
BMI (kg/m2) | 34.9 (29.4, 40.9) | 33.0 (27.3, 40.0) | 33.5 (28.1, 40.4) | 1 (0.4%) |
PaO2/FIO2 ratio | 75 (62, 88) | 66 (53, 83) | 69 (55, 85) | 5 (1.9%) |
Creatinine (mg/dL) | 0.9 (0.7, 1.4) | 1.6 (1.0, 2.8) | 1.4 (0.8, 2.3) | 1 (0.4%) |
SOFA Score | 7 (5, 9) | 10 (8, 13) | 9 (7, 12) | 7 (2.7%) |
RESP Score | 3 (2, 5) | 3 (1, 5) | 3 (1, 5) | 0 (0.0%) |
Survival to discharge | 41 (50.0%) | 114 (65.1%) | 155 (60.3%) | 0 (0.0%) |
Ventilator days prior to ECMO | 5 (1, 8) | 2 (1, 5) | 3.0 (1.0, 6.0) | 0 (0.0%) |